Cytokine-inducible SH2-containing protein suppresses PRL signaling by binding the PRL receptor

Endocrinology

Volumn 142, Issue 12, 2001, Pages 5286-5293

  Dif, Fariel ^a,b   Saunier, Elise ^a   Demeneix, Barbara ^b   Kelly, Paul A ^a   Edery, Marc ^a,c  

^a Médicale Unité Mixte de Recherche en Santé 938   (France)

^b CNRS   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CASEIN; CYTOKINE; PROLACTIN; PROLACTIN RECEPTOR; STAT5 PROTEIN;

ARTICLE; CONTROLLED STUDY; GENE TARGETING; GENETIC TRANSFECTION; HORMONE ACTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; SIGNAL TRANSDUCTION;

EID: 0035209861     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.142.12.8549     Document Type: Article

References (38)

1. Prolactin and its receptor: Actions, signal transduction pathways and phenotypes observed in prolactin receptor knockout mice
2. Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription
3. Activation of Stat5a and Stat5b by tyrosine phosphorylation is tightly linked to mammary gland differentiation
4. Inhibition and restoration of prolactin signal transduction by suppressors of cytokine signaling
5. SOCS-1, -2, -3: Selective targets and functions downstream of the prolactin receptor
6. Cytokine-inducible SH2 protein (CIS3) and JAK2 binding protein (JAB) abolish prolactin receptor-mediated STAT5 signaling
7. Negative regulators of cytokine signal transduction
8. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality
9. SOCS1 is a critical inhibitor of interferon γ signaling and prevents the potentially fatal neonatal actions of this cytokine
10. SOCS3 is essential in the regulation of fetal liver erythropoiesis
11. Gigantism in mice lacking suppressor of cytokine signalling-2
12. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIF and IL-6 signal transduction
13. CIS3 and JAB have different regulatory roles in interleukin-6 mediated differentiation and STAT3 activation in M1 leukemia cells
14. Suppression of STAT5 functions in liver, mammary glands, and T cells in cytokine-inducible SH2-containing protein 1 transgenic mice
15. SOCS/CIS protein inhibition of growth hormonestimulated STAT5 signaling by multiple mechanisms
16. Role of the cytokine-inducible SH2 protein CIS in desensitization of STAT5b signaling by continuous growth hormone
17. Functional activity of the human prolactin receptor and its ligands
18. Tyrosine docking sites of the rat prolactin receptor required for association and activation of Stat5
19. High-efficiency transformation of mammalian cells by plasmid DNA
20. Comparative endocrinology of prolactin
21. Antagonistic properties of human prolactin analogs that show paradoxical agonistic activity in the Nb2 bioassay
22. A novel cytokine-inducible gene CIS encodes an SH2-containing protein that binds to tyrosine-phosphorylated interleukin 3 and erythropoietin receptors
23. CIS, a cytokine-inducible SH2 protein, is a target of the JAK-STAT5 pathway and modulates STAT5 activation
24. Dual effects of suppressor of cytokine signaling (SOCS-2) on growth hormone signal transduction
25. Transgenic models of growth hormone action
26. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins
27. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction
28. Prolactin-induced proliferation of Nb2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase JAK2
29. Cloning and characterization of novel CIS family genes
30. SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130
31. Suppressor of cytokine signaling-3 preferentially binds to the SHP2-binding site on the shared cytokine receptor subunit gp130
32. CIS3/SOCS-3 suppresses erythropoietin (EPO) signaling by binding the EPO receptor and JAK2
33. Suppressor of cytokine signaling (SOCS)-3 protein interacts with the insulin-like growth factor-I receptor
34. STAT5A-deficient mice demonstrate a defect in granulocyte-macrophage colony-stimulating factor-induced proliferation and gene expression
35. Stat5 is required for IL-2-induced cell cycle progression of peripheral T cells
36. Stat5a and Stat5b proteins have essential and nonessential, or redundant, roles in cytokine responses
37. Proteasomes regulate erythropoietin receptor and signal transducer and activator of transcription 5 (STAT5) activation. Possible involvement of the ubiquitinated CIS protein
38. Human growth hormone-variant demonstrates receptor binding profile distinct from that of normal pituitary growth hormone